International Sarcoma Career Development Award: Eligibility Criteria

The Career Development Award program is specifically intended to help clinician-scientists make the critical transition from training toward independence as clinical investigators.

Applicant Requirements

  • Clinician-scientist conducting research in sarcoma or related diseases
  • A foreign equivalent of a M.D., D.O. from an accredited institution
  • 0-5 years post final subspecialty training
  • Full-time faculty level or equivalent position at an academic medical institution or intent to join academic medical institution
  • Ability to spend 50-75% of time during award period dedicated to research
  • Non United States Citizen
  • Not supported by another career development award (ex. NIH K08 or K23, ASCO, ACRA)

 

Institutional Requirement

The institution must agree to provide the grantee with protected time equal to at least 50% but preferably 75% of his/her professional time to spend conducting research. The intent of this award is to help establish the grantee as an independent clinical investigator, with protected time, dedicated laboratory space (as needed), and appropriate resources.

Research Requirement

Grantees are required to spend 50-75% of their professional time on research. For example, if an investigator’s total effort is equivalent to an average of 60 hours per week, an average of 30-45 hours per week must be devoted to research. Of these hours, an average of 20-30 hours per week must be devoted to the project in this proposal.

Institutional Review Board Approval

The grantee may not conduct activities supported by the SARC Career Development Award that involve human subjects until a copy of the Institutional Review Board approval is received at SARC. Institutional Review Board approval is not required at the time of proposal submission. However, if a grant is awarded, Institutional Review Board approval should be in place by the grant start date, July 1, 2013. We recommend that you coordinate with your Institutional Review Board to ensure timely approval.